Poster: MPN-483 Thrombocytopenic Myelofibrosis (MF) Patients Previously Treated With a JAK Inhibitor in a Phase 3 Randomized Study of Momelotinib (MMB) versus Danazol (DAN) [MOMENTUM]

Authors :: Aaron Gerds
Srdan Verstovsek
Alessandro Vannucchi
Haifa Kathrin Al-Ali
David Lavie
Andrew Kuykendall
Sebastian Grosicki
Alessandra Iurlo
Yeow Tee Goh
Mihaela Lazaroiu
Miklos Egyed
Maria Laura Fox
Donal McLornan
Andrew Perkins
Sung-Soo Yoon
Vikas Gupta
Jean-Jacques Kiladjian
Rafe Donahue
Jun Kawashima
Ruben Mesa
Source :: Clinical Lymphoma Myeloma and Leukemia. 22:S155
Publication Year :: 2022
Publisher :: Elsevier BV, 2022.

Full Text Access

Tools